Objectives: There is evidence that the gut microbiota plays a major role in the pathogenesis of diseases of the central nervous system through the gut-brain axis. The aim of the present study was to analyze gut microbiota composition in bipolar disorder (BD) and its relation to inflammation, serum lipids, oxidative stress, tryptophan (TRP)/ kynurenine (KYN) levels, anthropometric measurements and parameters of metabolic syndrome. Further, microbial community differences of individuals with BD compared with healthy controls (HC) were explored.
| INTRODUC TI ON
Bipolar affective disorder (BD) is one of the top 10 causes of global disability and premature mortality with enormous socioeconomic impact. Nevertheless, the neurobiological basis of BD is not sufficiently characterized. Relevant factors include structural brain changes, disturbances in neuroplasticity as well as chronobiology.
Pathophysiological causes are genetic and environmental factors, including defects in apoptotic, immune-inflammatory, neurotransmitter, neurotrophin and calcium signaling pathways. Additionally, alterations in oxidative and nitrosative stress, cellular bioenergetics, and membrane or vesicular transport have been found in BD. 1 To date, one of the most innovative und significant areas that still need to be investigated in terms of potential environmental factors contributing to BD is the intestinal community of microbes. As recurring affective episodes in BD are associated with a progressing decline in cognitive function, it is especially interesting that an expanding volume of evidence supports the view that cognitive and emotional processes can be altered by microbes acting through the gut-brain axis. 2, 3 Key findings show that on the one hand stress influences the composition of the gut microbiota, and bidirectional communication between the gut microbiota and the central nervous system (CNS) influences stress reactivity. 4 Several studies have indicated that gut microbiota influences behavior as well as immune provocation influences anxiety-and depressive-like behavior associated with alterations in microbiota. 4, 5 Alterations in microbiota might modulate plasticity and related serotonergic and γ-aminobutyric acid (GABA) ergic signaling pathways in the CNS. 5 Currently, most gut microbiota findings result from animal studies, and research in humans is only at its early stages. To our knowledge, up to now, only two studies have involved individuals with BD. 6, 7 Evans et al 7 compared the gut microbiota of individuals with BD and healthy controls (HC). They found a decreased fractional representation of Faecalibacterium in individuals with BD compared with HC, and found that the abundance of Faecalibacterium was negatively associated with self-reported burden of disease measures in BD individuals. The second study investigating microbiota in BD 6 focused on differences between individuals with BD taking or not taking atypical antipsychotics. A decreased species diversity was only found in females treated with atypical antipsychotics compared with females not taking the respective medication. More specifically, they found a reduction of Lachnospiraceae, Akkermansia and Sutterella. However, besides incomplete mood state information, both studies lack a proper characterization of BD individuals.
Bipolar disorder is known to be associated with a high risk of obesity and metabolic disturbances, which consequently lead to further medical complications, including a more complex illness presentation and a poorer prognosis. 8 there is strong evidence that behavioral factors including poor eating behavior and physical inactivity contribute to the progression of the disease. 14 As gut microbes are responsible for an enormous array of metabolic activities, for example they harvest energy from food, 15 the possibility of a bidirectional relationship between obesity in BD and microbiota changes seems likely. In this context, Hamdani et al 16 found that a manic episode could be treated by the application of charcoal, and supposed a role of the gut-brain axis influencing the clinical course of BD. Additionally, fermentation products of bacteria such as short chain fatty acids were found to control various immune responses and regulate the T-cell network. 17 As chronic low-grade inflammatory processes are known to play an important pathophysiological role in BD, 18 interactions of the gut microbiota with inflammatory processes are likely and of interest. In this context, also the production of neurotransmitters in the gut and the presence of different neurotransmitter receptors come into mind. Serotonin (5-HT), a metabolite of tryptophan (TRP), is mainly produced in the intestine and known to play an important role in the regulation of mood. Another metabolite of TRP is kynurenine (KYN), which is synthesized by indoleamine 2,3-dioxygenase (IDO), an enzyme that is upregulated in neuropsychiatric disorders related to immune system dysfunction. 19 It has been shown that the plasma 5-HT levels of conventional mice are significantly higher than in germ-free mice, who have no intestinal microbiota, 20 which is demonstrating the capacity of the microbiota to influence 5-HT levels. Studies relating microbiota composition with blood parameters (TRP, inflammatory and metabolic factors) in humans are strongly needed to confirm the described associations of the gut-brain axis found in animal studies.
Against this background, we hypothesized that the composition of the gut microbiota correlates with distinct changes in inflammatory and metabolic factors in individuals with BD and differs from that of HC. The objectives of the present study were: (i) to delineate the gut microbiota composition in relation to inflammatory and metabolic parameters as well as TRP/KYN levels in individuals with BD;
and (ii) to characterize possible differences of the gut microbiota in terms of diversity and/or abundance of bacterial taxa between BD individuals and HCs. with a method based on TBA-reaction and high-performance liquid chromatography (HPLC), which is broadly used in other scientific reports. 26 The TBA-reaction followed by HPLC and fluorometric detection was used to detect TBARS (Merck-Hitachi, Stuttgart, Germany).
| MATERIAL S AND ME THODS

| Participants
| Anthropometric measures and metabolic rating
To assess overweight and obesity, anthropometric parameters were collected (body mass index [BMI], waist-to-hip ratio, waist-to-heightratio). The BMI was calculated as the weight in kilograms divided by the square of height in meters. We defined normal-weight, overweight and obesity using the BMI cut-offs according to the World Health In our sample, we defined "metabolic syndrome" using the crite- 
| Stool sample -protocol for patients
All stool samples used for microbiota analysis were collected at the same day or 1 day after collection of the blood sample, and immediately frozen and stored at −20°C before DNA isolation. Interim storage and long-term sample storage (up to 14 years) at −20°C of faecal specimens guarantees high sample quality for 16S sequencing without altering results. PCR products were subjected to agarose gel electrophoresis. QIAquick (Qiagen, Hilden, Germany) gel extraction system was used to purify the band of the expected length (330 nt). DNA concentration of the final PCR product was raised with Picogreen fluorescence. Sequencing reactions were performed on Ion Torrent PGM using the Ion 400BP Sequencing Kit (Thermo Fisher Scientific). Sequences were split by barcode and transferred to the Torrent suite server.
| Sequencing
Unmapped bam files were used as input for bioinformatics analysis.
| Phylogenic analysis and bioinformatics
All sequences were initially trimmed by a sliding window quality filter with a width of 20 nt and a cutoff of Q20. DeconSeq 30 was used to eliminate reads shorter than 100 nucleotides or reads mapping the human genome. The reads were then subjected to error correction using the Acacia tool, 31 which led to an error correction of 10%-20% of reads. Subsequently, PCR chimeras were removed by Usearch algorithm 32 in de-novo and reference-based settings. 32 The final sequence files were then analyzed by QIIME 1.8 workflow scripts. 33 OTU search was performed using the parallel_pick_open_ reference_otus workflow script and the greengenes 13_8 reference database. OTUs were clustered using a 97% similarity threshold.
| Statistical analysis and visualization
Groupings supplied in the mapping file were tested for statistical significance using the QIIME implementation of the Adonis test (compare_categories.py script of QIIME version 1.8.0), and significance of individual bacterial strains was determined using the Kruskal-Wallis test (group_significance.py script of QIIME version 1.8.0). LEfSe 34 analysis was performed to detect statistically relevant strains in the study groupings. Species richness was calculated with the number of observed species and Chao-1-estimator. Data were rarified to 8000 sequences per sample. All remaining statistical calculations were performed in IBM SPSS Statistics Version 22.
| RE SULTS
| Sample characteristics
Sample characteristics of BD patients are displayed in Table 1 in which the means and standard deviations are given.
| Microbiota analysis in BD patients
Microbiota analysis was performed on a total of 42 stool samples (32 BD patients and 10 HC). After preprocessing, we obtained a total of 
| Alpha-diversity and disease parameters
To determine associations between alpha-diversity (Chao-1-estimator and number of observed species) and disease parameters within the BD group, we used Spearman's correlation analysis. Illness duration was inversely correlated with the number of observed species (R = −0.408, P = 0.021), indicating that the longer patients suffered from BD, the less bacterial species were present in their fecal microbiota ( Figure 1 ).
We did not find significant correlations of microbial diversity with serum concentrations of CRP, IL-6, lipid, TRP, KYN, oxidative stress parameters and depression levels. Furthermore, there were no significant correlations between alpha-diversity and anthropometric measurements.
| Bacterial taxa and disease parameters
We used LEfSe analysis to test for differential abundant microbial taxa in BD patients. 34 The median was used to divide the BD group into individuals showing high or low expressions of disease parameters.
| Inflammatory markers
First, we used the median to divide the group of BD patients according to inflammatory marker levels. LEfSe analysis revealed that BD patients with high IL-6 levels showed significantly higher abun- between the high and low CRP groups in bacterial clades to any significant extent.
| Lipids
The BD group with high total cholesterol levels harbored significantly more Clostridiaceae (LDA = 3.48, P = 0.004) compared with BD patients with low cholesterol. Individuals with low LDL cholesterol showed significantly higher abundances of Prevotellaceae (LDA = 4.28, P = 0.025) and the genus Prevotella (LDA = 4.28, P = 0.025).
There was no significant difference in bacterial taxa between high and low HDL groups.
| Tryptophan-metabolites
Individuals with high TRP differed significantly in the genus Lactobacillus (LDA = 4.73, P < 0.001), the family of Lactobacillaceae (LDA = 4.73, P < 0.001), the family of Coriobacteriaceae (LDA = 4.41, P = 0.019) and Clostridiaceae (LDA = 3.68, P = 0.044) from individuals with low TRP, while KYN showed no significant differences.
| Markers of oxidative stress
Individuals with BD showing high levels of TBARS also had significantly higher abundances of the genus Eubacterium (LDA = 2.30, P = 0.029). Low MDA levels occurred simultaneously with high relative abundances of the genus Faecalibacterium (LDA = 4.22, P = 0.031).
| Anthropometric measures and metabolic syndrome parameters
We divided individuals with BD into two groups depending on their 
| Clinically relevant depressive symptoms
We conducted a LEfSe analysis to show probable differences of bacterial clades between patients with and without clinically relevant depressive symptoms (BDI cut-off score 18), whereas three discriminative features could be identified: the family of Enterobacteriaceae (LDA = 3.12, P = 0.044) was more abundant in depressive BD patients, while the family of Clostridiaceae (LDA = 3.41, P = 0.048) and the genus Roseburia (LDA = 3.13, P = 0.016) were more abundant in already healthier BD patients.
| Microbiota of BD patients vs HC
In a second step, we included the HC group in the analysis. The characteristics of BD patients and HC are listed in Table 2 .
| Alpha-diversity between groups
Alpha-diversity was compared between BD patients and HC using the number of observed species, Chao-1-estimator, Shannon index and Simpson index. Figure 2 shows rarefaction plots for the number of observed species and Chao-1. Using the highest available sequencing depth (8000 sequences), no significant differences in the number of observed species (P = 0.179), Chao-1-diversity index (P = 0.767),
Shannon index (P = 0.217) and Simpson index (P = 0.379) could be observed between the groups. As diabetes and obesity could affect gut microbiota diversity, we excluded one BD patient suffering from diabetes mellitus and four patients with severe obesity (BMI > 35) to enhance the accuracy of our results. Again, there were no significant differences in the number of observed species (P = 0.133), Chao-1-diversity index (P = 0.696), Shannon index (P = 0.169) and Simpson index (P = 0.339).
| Beta-diversity between groups
Using beta-diversity analysis, both weighted (A) and unweighted (B)
principal component analysis (PCoA) UniFrac plots were generated in Figure S1A and B). After exclusion of the patient with diabetes and the patients with severe obesity (n = 4), still no significant differences could be detected ( Figure S2A and B).
| Differentially abundant bacterial clades between BD patients and HC
LEfSe was used to identify differential microbial abundances between BD patients and HC. This analysis revealed significant differences in bacterial clades from phylum to species level between BD patients and HC. Importantly, six features showed a markedly high LDA score (LDA ≥ 4.5) and total abundances in percent (Table 3) . The results after exclusion of the patient with diabetes and the patients with severe obesity are depicted in Table S1 .
| D ISCUSS I ON
In the current study, we describe associations between the gut microbiota and clinical parameters in a well-characterized cohort of individuals with BD, and identify differentially abundant bacterial taxa in comparison to a HC group. As hypothesized, we were able to find significant relationships between representations of several bacterial taxa and disease parameters in individuals with BD, and distinct differences between patients and HCs. Our data represent the first investigation of BD disease parameters, such as markers of inflammation, immune activation, metabolism and oxidative stress along with analysis of the gut microbiota in BD.
Alpha-diversity, which describes the number of different bacterial taxa prevalent in the gut, has been proved to be of potential relevance to the pathogenesis of various diseases. For example, a lower bacterial diversity is related to inflammatory bowel disease 35 and anorexia nervosa. 36 Conversely, in a recent study Jiang et al found increased alpha-diversity in patients with acute major depression compared with a HC group. 37 In our study we showed that alphadiversity correlated negatively with illness duration in BD individuals. This might be due to inflammatory processes in BD, which cause neurobiological and functional impairment increasing with illness duration. 38 Recently, Tatay-Manteiga et al described an association between biomarkers of inflammation and poorer functional outcome of BD patients by depicting differences in inflammation markers in BD patients in different stages of the disease. 39 On the other hand, our results could also be attributed to the continuous or prolonged use of psychopharmacological medication. 40 This would be in line with Jiang et al, where the increase of bacterial alpha-diversity was only found in active depression but not in responded major depressive patients after psychopharmacological treatment. 37 Another potential influencing factor for lower alpha-diversity in BD individuals with long illness duration might be poor nutrition. Poor diet quality was associated with twice the odds for BD. 41 Therefore, dietary patterns may be a factor influencing alpha-diversity in the long term.
However, longitudinal studies are needed to show whether the number of observed species decreases during the course of BD.
Findings of longitudinal studies may also be helpful to support the literature on the clinical use of biomarkers of neuroprogression and clinical staging models in BD. 38, 42 Looking more detailed into our analyses, we could identify ing from major depression when compared with HC. 37 We further found significant differences in the phylum of Actinobacteria and the family of Coriobacteriaceae between individuals with BD and HCs.
Actinobacteria and Coriobacteriaceae are common inhabitants of the GI-tract involved in lipid metabolism 43 and shown to correlate with cholesterol levels, 44 which could be the reason for finding them more abundant in the BD group.
As several studies have recognized an increased risk of individuals with BD to suffer from somatic comorbidities such as obesity, autoimmune disorders, diabetes and cardiovascular disease, 45 we hypothesized that distinct alterations of clinical parameters in BD are related to particular changes in the composition of the gut microbiota. BD has been related to alterations of the immune system; however, the exact mechanisms of immune dysfunction in BD remain unclear. As the gut microbiota has been shown to severely affect immune function, gut dysbiosis might be a factor contributing to immune alterations in BD. 46 For example, meta-analysis data depict increased activation of innate and cell-mediated immune processes in BD. 12 In our study, BD individuals with higher IL-6 levels showed significantly higher abundances of Lactobacillales, Streptococcaceae and Bacilli. An analogous correlation was found in the study of Yamashiro et al 47 in patients with ischemic stroke, where a high prevalence of Lactobacillus ruminis was positively correlated with IL-6 levels.In the study of Million et al, the genus Lactobacillus was found to be more abundant in obese study participants compared with lean controls. 48 Similarly, in our study, individuals with BD and higher BMI harbored significantly more Lactobacilli when compared with the lower BMI group. Moreover, the family of Lactobacillaceae and the genus Lactobacillus were more abundant in BD individuals with metabolic syndrome. Therefore, Lactobacilli could be a factor contributing to obesity in BD; however, we cannot deduce a causal relationship from the results of our cross-sectional study.
Importantly, oxidative stress has been found to trigger rapid shifts in intestinal microbial groups, 49 and obesity is associated with a highly prevalent state of chronic oxidative stress in BD. In our study, individuals with higher oxidative stress, measured by MDA levels, showed high abundances of Faecalibacterium. Noteworthy, the BD individuals investigated in the current study had significantly
higher BMI values than HC. In obese individuals, antioxidant defenses are attenuated because of a decreased intake of antioxidants or an increased utilization of these molecules, 50 which could potentially have influenced microbial community composition.
From a psychiatric perspective, it is interesting that the association between neurotransmitters and gut microbiota has already been investigated. The results showed that most of our neurotransmitters can be produced by gut bacteria. For example, Lactobacillus species produce acetylcholine and GABA; Bifidobacterium species also synthesize GABA; Escherichia produces noradrenaline, 5-HT and dopamine; Streptococcus and Enterococcus synthesize 5-HT; and
Bacillus species produce dopamine and noradrenaline. 3 TRP, which is a 5-HT precursor, has been shown to be altered in BD along with changes in KYN pathway metabolites. 51 In our study, high TRP levels were associated with the family of Clostridiaceae and Roseburia. However, the results must be interpreted with caution due to another limitation of the study, the small sample size of groups. Nevertheless, our results support the current literature on the complex interaction between the gut-brain axis and BD.
Further studies on state-and trait-related effects and influences of BD on gut microbiota are highly interesting and needed.
A further limitation is that neither individuals with BD nor controls received a standardized diet. The gut microbiota composition is influenced by dietary changes, 57 which must be taken into account when interpreting our results. This can also be said for lifestyle parameters, 58-60 which were not explicitly assessed in our study participants. Additionally, BD individuals remained on their usual pharmacotherapy, which could have had an impact on the gut microbiota. 6 Therefore, the correlation between low species richness and long disease duration could in part be due to medication 
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